TransMedics Group, Inc. (TMDX)
$88.06-$3.69 (-4.02%) Today
Stephanie Lovell
Nicholas Corcoran - OfficerTransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 1 | 9,624 | $722K |
| Grant or award | 6 | 235,563 | |
| Option exercise | 2 | 38,570 | |
| Bona-fide gift | 1 | 18,000 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
36 Form 4 filings on record, the earliest from Oct 3, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| James R. Tobin - Director | Gift | Common Stock | 18,000 | $0.00 | - | |
| Nicholas Corcoran - Officer | Grant or award | Common Stock | 11,727 | $0.00 | - | |
| Nicholas Corcoran - Officer | Grant or award | Stock Option (Right to Buy) | 17,784 | $0.00 | - | |
| Gerardo Hernandez - Officer | Grant or award | Common Stock | 17,246 | $0.00 | - | |
| Gerardo Hernandez - Officer | Grant or award | Stock Option (Right to Buy) | 26,153 | $0.00 | - | |
 Waleed H. Hassanein - Officer | Grant or award | Common Stock | 49,669 | $0.00 | - | |
| Waleed H. Hassanein - Officer | Grant or award | Stock Option (Right to Buy) | 112,984 | $0.00 | - | |
| Thomas J. Gunderson | Option exercise | Common Stock | 19,285 | $2.21 | $43K | |
| Thomas J. Gunderson | Open-market sale | Common Stock | 9,624 | $75.06 | $722K | |
| Thomas J. Gunderson | Option exercise | Stock Option (Right to Buy) | 19,285 | $0.00 | - | |
| Stephanie Lovell | Grant or award | Common Stock | 2,922 | $0.00 | - | |
| David Weill | Grant or award | Common Stock | 2,922 | $0.00 | - | |
| Merilee Raines | Grant or award | Common Stock | 2,922 | $0.00 | - | |
| Thomas J. Gunderson | Grant or award | Common Stock | 2,922 | $0.00 | - | |
| Edward M. Basile | Grant or award | Common Stock | 2,922 | $0.00 | - | |
| James R. Tobin | Grant or award | Common Stock | 2,922 | $0.00 | - | |
| Edwin M. Kania Jr. | Grant or award | Common Stock | 2,922 | $0.00 | - | |
 Matthew S. Forsyth - Officer | Grant or award | Common Stock | 15,409 | $0.00 | - | |
| Matthew S. Forsyth - Officer | Grant or award | Stock Option (Right to Buy) | 23,171 | $0.00 | - | |
| Stephanie Lovell | Open-market sale | Common Stock | 1,193 | $149.62 | $178K | |
| David Weill | Option exercise | Common Stock | 3,571 | $14.20 | $51K | |
| David Weill | Open-market sale | Common Stock | 3,571 | $146.82 | $524K | |
| David Weill | Option exercise | Stock Option (Right to Buy) | 3,571 | $0.00 | - | |
| Gerardo Hernandez - Officer | Open-market sale | Common Stock | 5,912 | $147.21 | $870K | |
| Gerardo Hernandez - Officer | Option exercise | Stock Option (Right to Buy) | 1,324 | $0.00 | - | |
| Gerardo Hernandez - Officer | Option exercise | Stock Option (Right to Buy) | 5,912 | $0.00 | - | |
| Gerardo Hernandez - Officer | Option exercise | Common Stock | 1,324 | $77.12 | $102K | |
| Gerardo Hernandez - Officer | Option exercise | Common Stock | 5,912 | $69.84 | $413K | |
| Gerardo Hernandez - Officer | Open-market sale | Common Stock | 375 | $139.12 | $52K | |
| Gerardo Hernandez - Officer | Open-market sale | Common Stock | 1,324 | $147.21 | $195K | |
| Anil P. Ranganath - Officer | Open-market sale | Common Stock | 864 | $139.12 | $120K | |
| Nicholas Corcoran - Officer | Tax withholding / forfeiture | Common Stock | 984 | $135.30 | $133K | |
| Nicholas Corcoran - Officer | Open-market sale | Common Stock | 2,966 | $139.12 | $413K | |
 Giovanni Cecere - Officer | Grant or award | Common Stock | 11,082 | $0.00 | - | |
| Giovanni Cecere - Officer | Grant or award | Stock Option (Right to Buy) | 16,734 | $0.00 | - | |
| Gerardo Hernandez - Officer | Open-market sale | Common Stock | 920 | $139.62 | $128K | |
| David Weill | Option exercise | Common Stock | 5,000 | $14.20 | $71K | |
| David Weill | Open-market sale | Common Stock | 5,000 | $138.64 | $693K | |
| David Weill | Option exercise | Stock Option (Right to Buy) | 5,000 | $0.00 | - | |
| Anil P. Ranganath - Officer | Option exercise | Common Stock | 3,000 | $93.88 | $282K | |
| Anil P. Ranganath - Officer | Open-market sale | Common Stock | 3,000 | $145.22 | $436K | |
| Anil P. Ranganath - Officer | Option exercise | Stock Option (Right to Buy) | 3,000 | $0.00 | - | |
| Waleed H. Hassanein - Officer | Open-market purchase | Common Stock | 8,775 | $114.00 | $1.00M | |
| Edward M. Basile | Option exercise | Common Stock | 4,142 | $0.70 | $3K | |
| Edward M. Basile | Open-market sale | Common Stock | 4,142 | $130.45 | $540K | |
| Edward M. Basile | Option exercise | Stock Option (Right to Buy) | 4,142 | - | - | |
| Waleed H. Hassanein - Officer | Open-market purchase | Common Stock | 8,400 | $118.68 | $997K | |
| Waleed H. Hassanein - Officer | Open-market purchase | Common Stock | 6,617 | $116.08 | $768K | |
| Waleed H. Hassanein - Officer | Open-market purchase | Common Stock | 1,858 | $116.85 | $217K | |
| Edward M. Basile | Option exercise | Common Stock | 4,143 | $0.70 | $3K | |
| Edward M. Basile | Open-market sale | Common Stock | 4,143 | $125.51 | $520K | |
| Edward M. Basile | Option exercise | Stock Option (Right to Buy) | 4,143 | - | - | |
| James R. Tobin | Grant or award | Common Stock | 2,134 | $0.00 | - | |
| Merilee Raines | Grant or award | Common Stock | 2,134 | $0.00 | - | |
| Edwin M. Kania Jr. | Grant or award | Common Stock | 2,134 | $0.00 | - | |
| Gerardo Hernandez - Officer | Grant or award | Common Stock | 12,463 | $0.00 | - | |
| Gerardo Hernandez - Officer | Grant or award | Stock Option (Right to Buy) | 18,922 | $0.00 | - |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR |
TransMedics Group, Inc. (TMDX) had 5 insider filings in the last 90 days, with the most recent on 2026-08-17. The full record for TMDX runs to 36 Form 4 filings, the earliest from 2024-10-03. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of TMDX were filed in the last 90 days. 4 purchases are on record for this company.
1 insider sale of TMDX was filed in the last 90 days, totaling $722K.
This page tracks TMDX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add TMDX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
